Newsletter comparison
CIDRAP News vs STAT Morning Rounds
Short answer: Choose CIDRAP News for depth in infectious disease and preparedness. Choose STAT Morning Rounds for a broader health-and-science morning edit. Keep both if outbreaks are central to your work but not the only developments that matter.[1][2][3][4][5][6]
An independent guide. Scottie isn't affiliated with, endorsed by, or sponsored by CIDRAP News and STAT Morning Rounds. Each publication owns its name, writing, and subscription terms.
A brief from both newsletters · July 31, 2026
See both newsletters in one brief
See what made the brief, what didn't, and the original links behind every included story.
In this brief: Scottie kept the selected stories separate because they added different value.
Reader priorities
A health and science professional wants timely infectious-disease evidence without losing the wider medicine, agency, and research context.
These are illustrative priorities, not a customer’s data.
What made the brief
- CIDRAP News20 read · 4 included
- STAT Morning Rounds20 read · 4 included
This brief includes up to 365 days of issues so less-frequent publications aren't judged on an empty week.
Scottie
Scottie example brief
July 31, 2026 · Executive brief
01 / The rundown
- A re-emerging Ebola outbreak in Central Africa threatens dense urban centers while reduced agency capacity hinders containment efforts.
- A 30-minute tongue swab test for tuberculosis demonstrated high accuracy in a multi-country trial, offering a non-sputum diagnostic alternative.
- Phase 2 trial results for sorfequiline show faster tuberculosis clearance, paving the way for significantly shorter treatment regimens.
02 / The briefing
01 / main
Ebola outbreak expands as international response systems strain
The takeaway: A fresh Ebola outbreak in Uganda and the Democratic Republic of the Congo is threatening densely populated areas. Weakened capacity at the WHO and CDC, combined with underutilized U.S. treatment centers, risks turning the disease endemic across Central Africa.
Concrete details
- The current outbreak spreads through one of Africa's most densely populated regions as global health agencies operate at reduced capacity.
- Unutilized specialized U.S. treatment facilities and reduced agency resources complicate long-term containment efforts across the region.
Why it matters for this reader: As an infectious disease specialist, monitoring systemic agency gaps and containment failures provides vital context for global outbreak preparedness and therapeutic deployment.
Original sourcesSTAT Morning RoundsSTAT Morning RoundsSTAT Morning Rounds
02 / main
Non-sputum tongue swab test meets global standards for TB
The takeaway: A multi-country evaluation across seven high-burden nations shows that Pluslife Biotech's battery-operated MiniDock MTB test reliably identifies tuberculosis using simple tongue swabs. The 30-minute test offers an accessible diagnostic option for patients unable to produce sputum.
Concrete details
- The test achieved 79.6% sensitivity and 99.5% specificity on tongue swabs among 1,380 evaluated patients.
- Hardware costs approximately $180 for the reader and thermolyze device, while single test cards cost roughly $4.
Why it matters for this reader: This non-sputum point-of-care platform offers actionable evidence to help you evaluate decentralized diagnostic strategies for hard-to-reach patient populations.
Original sourcesCIDRAP News
03 / main
Retail outlets frequently dispense unprescribed antibiotics in sub-Saharan Africa
The takeaway: Though expected trials on high-dose rifampin for tuberculous meningitis lack supporting data in the provided text, a featured meta-analysis reveals that 67.5% of retail medicine outlets in sub-Saharan Africa dispense antibiotics without prescriptions, driving AMR concerns.
Concrete details
- Analysis of 26 studies found a median non-prescription antibiotic dispensing rate of 67.5% across regional retail outlets.
- Over two-thirds of surveyed community pharmacies and medicine vendors dispensed antibiotics on demand for common self-limiting conditions.
Why it matters for this reader: For your broader surveillance work, tracking antimicrobial stewardship breakdowns in retail settings highlights community drivers of drug resistance.
Original sourcesCIDRAP News
04 / main
Novel TB antibiotic sorfequiline accelerates bacterial clearance in trial
The takeaway: Phase 2 clinical trial results show that adding sorfequiline to pretomanid and linezolid cleared tuberculosis bacteria faster than standard care. The findings support moving the drug into Phase 3 trials aimed at creating a shorter, simplified regimen.
Concrete details
- The 100 mg sorfequiline regimen achieved 59% sputum conversion at week 8 compared to 45% for standard care.
- The 309-patient trial across five countries evaluated sorfequiline to potentially shorten treatment down to one month of oral pills.
Why it matters for this reader: Tracking new therapeutic regimens gives you early research context on pipeline candidates that could transform standard tuberculosis treatment protocols.
Original sourcesCIDRAP News
05 / main
Household formula warmers linked to infant Legionnaires' disease case
The takeaway: While anticipated data on adolescent TB lung outcomes is absent from the provided text, a documented case details an immunocompromised infant who contracted Legionella pneumophila from a household formula mixer that stored standing warm water.
Concrete details
- Testing confirmed Legionella bacteria in both the filtered household water and the internal reservoir of the formula mixer.
- Health officials advise boiling water above 158 degrees Fahrenheit before mixing formula for infants with immunocompromising health conditions.
Why it matters for this reader: Understanding environmental exposure routes for opportunistic pathogens strengthens your clinical perspective on pathogen transmission and vulnerable patient care.
Original sourcesCIDRAP News
06 / main
Parasitic diarrhea outbreak expands across US with thousands unconfirmed
The takeaway: CDC officials report over 1,600 confirmed cases of cyclosporiasis, with more than 5,100 additional cases pending analysis. Investigators suspect contaminated produce like lettuce or salad greens, though specific suppliers remain unidentified as symptoms take two weeks to appear.
Concrete details
- The CDC has recorded 1,645 lab-confirmed cyclosporiasis cases while evaluating more than 5,100 additional suspected illness reports.
- Symptoms can take up to two full weeks to manifest after initial exposure to contaminated fresh food products.
Why it matters for this reader: Real-time tracking of active foodborne outbreaks keeps you informed on active epidemiological threats and public health agency investigations.
Original sourcesSTAT Morning Rounds
Action items
- Review the MiniDock MTB trial data to evaluate non-sputum diagnostic feasibility for your clinical testing protocols.
- Assess pipeline progress on Phase 2 sorfequiline trial outcomes to inform future tuberculosis therapy research strategies.
See every issue behind this brief
Ebola outbreak response flaws, vaccine delays, and therapeutic development
- Ebola outbreak exposes a fractured outbreak response systemSTAT Morning Rounds · Included
- The race for an Ebola therapy beginsSTAT Morning Rounds · Included
- Ebola outbreak nears milestone, while a vaccine remains months awaySTAT Morning Rounds · Included
Overview of active cyclosporiasis parasitic diarrhea outbreak
- What to know about the parasitic diarrhea outbreakSTAT Morning Rounds · Included
Persistent lung impairment in adolescent TB survivors post-cure
TB and HIV costs
- TB costs in poor countries exceed those of HIV, estimates suggestCIDRAP News · Read, not included
US TB outbreaks
- Large TB outbreaks in the United States decline slightly in recent years, CDC reportsCIDRAP News · Read, not included
- Ultrasensitive test detects tuberculosis DNA in unexpected number of US patientsCIDRAP News · Read, not included
Non-sputum tongue swab TB test evaluated in seven countries
- No sputum needed: Easy-to-use TB test shows accuracy in 7-country analysisCIDRAP News · Included
Phase 3 TB vaccine
- TB vaccine candidates offer limited protection in phase 3 trialCIDRAP News · Read, not included
US TB case decline
- CDC data suggest small decline in US TB casesCIDRAP News · Read, not included
Missed European TB cases
- More than 1 in 5 new TB cases in Europe are missed, analysis findsCIDRAP News · Read, not included
Pandemic impact on TB
- Pandemic-related factors may lead to nearly 3,000 excess TB cases, 1,100 deaths by 2035CIDRAP News · Read, not included
Tuberculosis funding cuts model
- Tuberculosis funding cuts could cost households up to $80 billionCIDRAP News · Read, not included
Shorter TB prevention regimens
- Study supports shorter treatment regimens for TB preventionCIDRAP News · Read, not included
High-dose rifampin fails in tuberculous meningitis trial
- High-dose rifampin fails to cut tuberculous meningitis deaths, may worsen outcomesCIDRAP News · Included
Phase 2 trial indicates sorfequiline combination may shorten TB therapy
- Phase 2 data suggest new drug could unlock shorter TB treatmentCIDRAP News · Included
WHO global TB report
- WHO cites progress against TB globally but warns about reduced fundingCIDRAP News · Read, not included
WHO novel TB vaccines
- WHO voices concerns about equitable access to novel TB vaccinesCIDRAP News · Read, not included
WHO immunization program benefits
- In its 50-year history, global vaccination program generated $16 in benefits for every $1 investedCIDRAP News · Read, not included
Global public health progress
- Fragile progress on global public health under threatCIDRAP News · Read, not included
E coli and TB
- Quick takes: More E coli tied to raw cheese, drug-resistant Shigella in UK, TB funds for SudanCIDRAP News · Read, not included
CDC acting director rules
- Quick takes: Hemorrhagic fever in DR Congo, testing option for TB, CDC acting director countdownCIDRAP News · Read, not included
USAID cuts death toll
- Quick takes: Death toll from USAID cuts, withdrawal of chikungunya vaccine, funding for updated Ebola vaccineCIDRAP News · Read, not included
HHS vaccine committee charter
- HHS vaccine committee quietly gets new charterSTAT Morning Rounds · Read, not included
Senate health hearing
- STAT+: Spring forward forever? Another daylight saving debate arrives in CongressSTAT Morning Rounds · Read, not included
Presidential fitness test
- STAT+: More frequent, more intense, and longer heat waves pose health risks for AmericansSTAT Morning Rounds · Read, not included
Anthony Fauci diary entries
- Anthony Fauci’s pandemic-era diary entriesSTAT Morning Rounds · Read, not included
Ultra-processed baby foods trend
- A trend that isn’t fading, ultra-processed baby foodsSTAT Morning Rounds · Read, not included
Diarrhea-causing parasite outbreak
- A new, separate outbreak of the diarrhea-causing parasiteSTAT Morning Rounds · Read, not included
Healthcare job dissatisfaction study
- Job dissatisfaction and health care access uncertainty grows in the U.S., new study findsSTAT Morning Rounds · Read, not included
FDA electric shock ban
- FDA quietly pushes back deadline on electric shock banSTAT Morning Rounds · Read, not included
FDA leadership vacancy
- Who’s going to run the FDA?STAT Morning Rounds · Read, not included
Alcohol as public health
- A neglected issue in pedestrian, biker deathsSTAT Morning Rounds · Read, not included
FDA peptide panel preview
- Expect a clash at today’s FDA peptide panelSTAT Morning Rounds · Read, not included
Abortion pills political push
- A renewed push from the right against abortion pillsSTAT Morning Rounds · Read, not included
Testosterone hormone medication access
- Who can access testosterone hormone medication in the U.S.?STAT Morning Rounds · Read, not included
Newborn vitamin K shot
- The risk of refusing a newborn’s vitamin K shotSTAT Morning Rounds · Read, not included
Health insurance costs
- Caregivers brace for pay cuts, and maybe homelessnessSTAT Morning Rounds · Read, not included
Fourth of July history
- Another big premium hike on the horizonSTAT Morning Rounds · Read, not included
The useful difference
The difference that matters
CIDRAP News is a focused university-center source on outbreaks, vaccines, antimicrobial resistance, and preparedness. STAT Morning Rounds scans more broadly across medicine, life science, public health, and federal agencies.[1][2][3][4][5][6]
What each is best for
CIDRAP News
CIDRAP News contributes research-centered infectious-disease reporting from a university public-health and preparedness program.[1][2][3]
STAT Morning Rounds
STAT Morning Rounds contributes a concise scan across medicine, life science, agencies, and public-health developments beyond infectious disease.[4][5][6]
When it’s worth reading both
The pair earns its place when an outbreak story has implications for research, regulation, or care outside the infectious-disease beat. Scottie can connect the event while retaining methods and caveats.[1][2][3][4][5][6]
Sources and official links
- CIDRAP News official publication
- Teen TB survivors may have reduced lung function, disability for up to 2 years post-treatment
- In its 50-year history, global vaccination program generated $16 in benefits for every $1 invested
- STAT Morning Rounds official publication
- Ebola outbreak nears milestone, while a vaccine remains months away
- A neglected issue in pedestrian, biker deaths